To various degrees, almost all diseases tend to aggregate familially (1) . Many common diseases, such as cardiovascular disease and cancer, have been shown to be familially aggregated. In fact, family history has long been used as a risk factor for disease in epidemiology (2) . Presumably, the familiality can be attributed to genetic similarity (the existence of a genetic etiologic mechanism), environmental similarity (risk factors common to family members), or a combination of both. The ultimate goal of genetic epidemiology is to be able to distinguish between genetic susceptibility, environmental impact, and gene-environment interaction, and to be able to quantify their relative importance as risk factors that influence morbidity or mortality in the population (3) .
To achieve this goal, investigators must identify any major genetic factors and any environmental factors. To start with, an important question can be raised: Can observed aggregation of the disease of interest be explained by familial aggregation of environmental risk factors? This question is an important one, because the answer to it is likely to affect the research strategy or approach one uses to unlock the etiology of the disease. If the answer is affirmative, then the epi-demiologic approach is probably favored. If it is largely negative, then a genetic approach may be effective. Indeed, in light of the remarkable success of the genetic approach in identifying genes responsible for simple genetic diseases such as cystic fibrosis, and in view of the powerful molecular technologies now available, the use of the genetic approach is attractive-particularly considering the fact that the accurate measurement of risk exposures is typically difficult because of substantial expense, complexity, a lengthy time scale, and measurement errors.
In addressing this question, Khoury et al. (4) considered a simple statistical model and investigated whether familial aggregation of disease could be explained by familial aggregation of environmental risk factors. They concluded that "simple familial clustering of environmental factors is unlikely to account entirely for familial aggregation of disease," and that "genetic factors ought to play an important role in causing familial aggregation" (4, p. 674 ). This conclusion, if true, has profound importance. For a disease with strong familial aggregation, if no environmental risk factor (familially aggregated or otherwise) has been found to strongly affect disease risk, then the familiality can be taken as evidence (albeit tentative) that genetic factors are the major culprit and should logically be pursued accordingly.
The conclusion, while correct, is based on several fairly stringent assumptions. For example, it assumes that there is no ascertainment-bias or overreporting among relatives of cases. When samples are ascer-1122 Guo tained in a biased manner, as is often the case in genetic epidemiologic research, the sibling recurrence risk ratio will be inflated, sometimes substantially (5). Other assumptions, such as the assumption of no interaction between risk factors and no multilevel risk factors, can be violated in practice.
In this paper, I revisit this issue using a model encompassing that of Khoury et al. and based on less stringent assumptions. I show that familial aggregation of disease could be explained by multiple environmental risk factors which also are familially aggregated and which interact with each other in a complicated fashion. On the basis of these findings, I suggest ways to minimize the environmental effect on disease familiality.
METHODS

Measures of familial aggregation of diseases
Two measures for familial aggregation of disease are commonly used in epidemiology. One is the sibling recurrence risk ratio, which is defined as the ratio of the risk of disease manifestation given that one's sibling is affected to the disease risk in the general population. Khoury et al. (4) used the measure of sibling recurrence risk, not the ratio. Since the recurrence risk ratio, often denoted X s , is more widely used in human genetics (6) , I consider X s in this paper. The other measure is the sibling relative risk, denoted £$ hereafter, which is defined as the relative risk of disease for siblings of cases compared with siblings of controls. A significant deviation from unity for either measure provides evidence for familial aggregation.
Consider a disease with a population prevalence P. Suppose two siblings are taken at random from the population. We assume that there is no birth order effect, no sex effect, and no variable age of onset. In other words, the two siblings are symmetric or similar in every respect except perhaps disease status. If X, is the random variable denoting the disease status of sibling i (i = 1, 2), with X, = 1 if sibling i is affected and 0 otherwise, then the above two definitions can be written as (6) Pr(X 2 = The sibling relative risk is defined as (4)
It is clear from equations 1 and 2 that when P is very low, e.g., P ^ 0.01, k s ~ £$. Consequently, we can focus on one measure, e.g., X s , unless the population prevalence P is moderate. As is explained below, X s has nicer properties in some respects than C^. It is also clear that to evaluate the magnitude of either X s or Cg, one needs to evaluate the covariance between X x and X 2 .
Note that while the above two measures are defined for siblings, similar measures of familiality can also be defined for other types of relatives such as parentoffspring pairs. The following development does not depend on the sibling relationship. Therefore, the derivations and conclusions are applicable to other types of relatives.
The single risk factor model
We first consider a single risk factor model. In contrast to the case considered by Khoury et al. (4) , which was defined by a dichotomous risk factor, here we assume that the risk factor may have more than two levels of exposure. More formally, suppose that the risk factor has m levels of exposure, with a population frequency u h i= 1, ..., m. Suppose further that the conditional probability that an individual, taken randomly from the population, is affected given exposure level i is Pr(X = 1 \E = i) = P h i = 1, ..., m, where £ is a random variable denoting his exposure level. Obviously, the population prevalence P = 2™=
We can consider the model
Pr(X= 1\E) = P + a E .
Since £ is a random variable, so is its a £ . For a given exposure level i, the realized (and centered) values of the random variable a £ are a, = P t -P, which is a well defined quantity that measures the deviation from average disease risk due to exposure level i. It can be easily verified that E(a E ) -2r=i«A = 0. For future convenience, we denote
When m = 2, in particular, it is easy to see that 2 -It is clear that V measures the variability of the disease risk due to the environmental risk factor.
Under this model, the covariance of the disease statuses of the two siblings can be easily computed, once the joint distribution of the exposure levels of the two is specified. Specifically, if we denote the exposure levels of the two siblings as E and £", respectively, and the joint distribution of exposure levels of the two siblings is uy (i,j = 1, ..., m), with u,
Combining the results in equations 1 and 4, we have Cov(a £ , a e ) = E(a E , a e ) = X "i
•j
Cov(a £ , a^) measures the covariability of the two siblings' disease risks due to the correlation of the risk exposures of the two. Note that, if a linear relation exists between the exposure level and disease risk, that is, P t = a -V bi, then p in equation 4 is identical to the correlation coefficient of the exposure levels of the two siblings. This is due to the fact that the Pearson correlation coefficient is invariant under linear transformations. In particular, if there are only two levels of exposure-for example, unexposed and exposed-then p in equation 4 is identical to the correlation coefficient of the exposure levels of the two siblings. = 1+^ (5) For m = 2, in particular, a more explicit result can be obtained. To see this, suppose that exposure levels 1 and 2 represent, e.g., "unexposed" and "exposed," respectively, which confers disease risks / and IR, where / is the background disease risk and R is the relative risk (in the notation of Khoury et al.) . In this case, the population prevalence P = /[I + u(R -1)], and 2 , where u is the exposure frequency. Furthermore, U = V/P 2 is no longer dependent on P. In addition,
One can verify easily that the above two equations yield numerical results that are the same as those of Khoury et al. (4) . When one attempts to dichotomize a multilevel risk factor, there is a possibility that the magnitudes of both measures will diminish as a result of dichotomization. To see this, suppose an m-level (m > 2) risk factor is dichotomized into two categories, unexposed and exposed. The unexposed group consists of people with exposure levels less than or equal to m 0 , for example, where 1 <, m^ < m. Consequently, the frequency of the exposed is u = 2™ Dmo+I u,, and the disease risks in the unexposed and exposed groups are/ = 2^l U /yS^i« t and« = 2f =fflb+I M/y S^^+iMjt, respectively. It can be shown (see Appendix) that:
The right-hand side of the inequality is the variance of disease risk when the risk factor is dichotomized. Thus, we can see that the variability, under the original exposure scale, of the disease risk due to the environmental risk factor is greater than or equal to that after dichotomization. In other words, by restricting one's attention to dichotomous exposure variables, one is restricted to seeing less variability of disease risk due to risk exposures. While the magnitude of both measures also depends on the covariability of disease risks, it is easy to see examples in which greater covariabil-ity is observed when multiple exposure levels are used than when the variable is dichotomized.
The two-risk-factor model
The above approach can be easily generalized to the case where there are several risk factors. Consider a case in which the risk of the disease of interest is associated with two risk factors. Suppose that the first risk factor has m, exposure levels, with marginal population frequencies u, (i = 1,..., m x ). The second risk factor has m^ exposure levels and population frequencies Vj (J -I, ..., m? ). Following Khoury et al. (4), we assume that the distributions of risk factors 1 and 2 in the population are independent. However, for siblings 1 and 2, the exposure levels for factor 1 (or 2) are correlated, although the two correlation coefficients are independent. That is, the joint distribution of risk exposures of the two siblings is such \hatf(i,j, k, I) -g(i, k)h(J,l) = u^Vp where f(i,j, k, /) is the probability that sibling 1 is exposed at levels i and j for factors 1 and 2, respectively, while the corresponding levels for sibling 2 are k and /, respectively. Note that, because of the independence, the population prevalence P -2,-2yM,-v,-P tf .
Denote {E x , E^) as the random vectors of risk exposures of the two risk factors for an individual. Then we can consider the following model:
If the conditional probability that an individual is affected, given exposure levels of i and j for the two risk factors, is P ijt then we can define «*= 2>/, y -P = />, -P
It is easy to see that a,, P y -, and £ /; are well defined. Moreover, the expectations of a £i , P^, and % EiEi are all zero, and so are the expectations of all cross-product terms.
Of particular interest is the case where m l = m^ = 2, a case also considered by Khoury et al. (4) . In this case,
Roughly speaking, a/s are the marginal effect of risk factor 1 and p ; 's are the marginal effect of risk factor 2, while £y's measure the interactional effect due to both risk factors. If the two risk factors interact in an additive fashion, then A = 0.
If (E lt £2) and (E{, £ 2 0 denote the random vectors of risk exposures for siblings 1 and 2, respectively, then p 2 and V 2 can be similarly defined. Again, when the marginal conditional probability P L (or Pj) is a linear function of the exposure level of factor 1 (or 2), p! (or P2) is identical to the correlation coefficient of the exposure levels of factor 1 (or 2) between the two siblings.
hi particular, when there are only two exposure levels-for example, unexposed and exposed-for both risk factors, Note that, by assuming R = R x + R 2 -1, the two risk factors are assumed to interact in an additive fashion. Since model 7 is an additive one, V l2 = 0 for A is zero, i.e., no interaction. In this case, it is interesting to note that, compared with equation 6, we have X s = 1 + c x U x + c 2 U 2 = 1 + fa -1) + fa -1) = X x + X 2 -1,
where X t can be viewed as the sibling recurrence risk ratio due to risk factor i {i = 1, 2). There are, of course, countless other models. One frequently used is the multiplicative model, which assumes that P& = IR X R 2 . As a result,
Thus, we have
The multiple-rlsk-factor model
The above models can be further extended to include multiple risk factors, as long as the distributions of all risk factors in the population are independent. For ease of exposition, I outline briefly the three-factor model, with each factor having only two exposure levels, unexposed and exposed. For risk factors 1, 2, and 3, the exposure frequencies are u, v, and w, respectively. Denote (£,, E 2 , E 3 ) as the random vectors of risk exposures of the three risk factors for an individual. Then, we can consider the following model:
where a, p, y, %, y, r\, and <f > can be defined on the basis of the conditional probability P iJk = Pr(Z = 1 |(i, j, k)):
Vi* = P* -P-Pi. ~ P.*
T) jk -P Jk -P-Pj, -P, M
where />,. = S^^vVV and P iJc = S? = lVj P iJk . In particular, when each of the three risk factors has two levels, unexposed and exposed, then a, = u(P L . -P 2 .), a, = -(1 -u)(P h , -P 2 ..) P> = V(P,. " P 2 ), P2 = -(1 -v)(P,. -P 2 ) Y, = w(P , -P. 2 
where A, = P n + P^ -(P 12 + P 21 ), © = 'Pin + ^212 + Pm + Pm ~ {Pm + ^211 + ^121 + ^222)-A2 and A 3 can be similarly defined. Note that while the A's measure the strength of interaction between two factors, 0 measures the strength of third-order interaction. Note also that 0 is the difference between the sums of background effect (i.e., P m = I) and effects when two factors (i.e., P 2n ) are present and the sums of the effects of a single factor and three factors (i.e., P 112 and P 222 ). It is not difficult to generalize to the case in which four or more risk factors are involved. If we assume a strictly additive model, that is, P m = /, P 211 = IR iy P m -IR 2 , Pyn = Ri + #3 ~ 1. and P222 = R\ + R 2 + R3 -2, etc., then all variances of disease risk due to second-and higher-order interactions vanish, yielding 
/=i
In contrast, under a multiplicative model, that is, P 122 = R 2 R 3 , P 222 = R&R3, etc., we have, by direct calculation, Uy = U,Uj, and U l23 = U X U 2 U 3 . Furthermore, The above results can be generalized to k dichotomous risk factors, whose distributions are independent in the population. If they interact in an additive fashion, then
If they interact multiplicatively, then
These results suggest that while individually each risk factor may contribute a minuscule portion to familial aggregation of the disease of interest, collectively they can result in a moderate or even substantial familial aggregation when there are many such risk factors that are all familially aggregated. For example, assuming that all X's are equal to 1.10, as long as there are more than 20 such risk factors if they interact additively or more than 12 risk factors if they interact multiplicatively, we would have a moderate overall X s > 3. If, on the other hand, all of these X s 's are not identical and they interact in a fashion other than additive or multiplicative, it is still possible that a collection of these risk factors can generate the desired magnitude of X s . Similar conclusions can be reached for £$.
NUMERICAL EXAMPLES Example 1: the effect of dlchotomlzatlon
Consider a hypothetical example in which there is a single risk factor with 10 exposure levels. The population prevalence P, the exposure frequencies «,-, and the corresponding disease risks />, are listed in table 1. Also shown in the table is the joint distribution of exposure levels for two siblings. It can be calculated that the correlation coefficient of risk exposure between the two siblings is 0.471. However, the correlation coefficient of disease risks, p, is 0.661. By direct calculation, the variance of disease risk V = 9.7 x 10~5; hence, X s = 2.408 and £s = 2.432.
If the highest four exposure levels were collapsed into one category and the lower six levels were collapsed into another (for example, the "exposed" and the "unexposed" categories, respectively), the exposure frequency would be 0. Using the same parameter combinations (except that R = 100 is replaced by R = 20), we consider the effect of multiple risk factors and of mode of interaction. Table 2 
1.00
1.00* 1.00
1.01 risk factors are strong (i.e., a large R), table 2 shows that there are cases (e.g., R = 5 and c = 0.50, or the two-factor ultramultiplicative model where R = 2 and c = 0.75) in which ^ can be moderate if risk factors interact multiplicatively or there are multiple risk factors. It is obvious that both X s and ^ can become substantially high when there are more than three risk factors, although each factor confers a small risk. The familial clustering is increased when there are supramultiplicative interactions and/or when the risk factors are highly correlated. The magnitude of the latter effect will require further quantification.
DISCUSSION
This paper, at first, confirms what Khoury et al. (4) concluded: For a disease with moderate or strong familial aggregation, a few binary risk factors alone are not likely to account entirely for such aggregation unless each of these risk factors is associated with an enormous risk and has a high correlation coefficient between relatives with respect to risk exposure. However, this paper also shows that the aggregation could be explained by multiple interacting risk factors that also are familially aggregated, each with multiple exposure levels.
By showing that familial aggregation of disease could be explained by familial aggregation of multiple and/or multilevel environmental risk factors and in what way, I am not claiming that diseases with familial aggregation are all caused by factors of environmental origin. Indeed, many common diseases may well have a genetic component. However, establishing compelling evidence for this may not be very easy. It is certainly not sufficient to argue for a genetic component based on the notion that no strong risk factors have been found. This paper only demonstrates how multiple, familially aggregated risk factors could result in familial aggregation of diseases, and hence underscores the need to carefully control environmental risk factors in examining genetic aspects of disease risk (see below).
For many human diseases, especially those of a chronic nature, it is not uncommon that there may be multiple risk factors. For example, over 200 factors have been suggested as risk factors for coronary heart disease (8) . The derivations of this paper show that familial aggregation of diseases could be explainable by multiple environmental factors, each carrying a low disease risk, that also are familially aggregated. These low-risk factors may be difficult to identify (9) in the first place. The lack of identification of strong risk factors is insufficient evidence on which to conclude that the origin of the disease must be genetic.
In this paper, as in the paper by Khoury et al. (4), we have assumed population homogeneity in risk exposure and independence of risk factor distributions in the population. These two assumptions were made mainly for mathematical convenience. In fact, numerous studies have shown that many risk factors are clustered (10-13). Clustering could arise either as heterogeneity in risk exposure due to different segments of the population having different exposure frequencies or as correlation of risk factors among family mem-bers, or from both sources. Such clustering would increase the heterogeneity of the disease distribution, making some pockets of the population more susceptible than others. As a result, the covariability of the disease risk among family members would increase, and according to equation 8 and definitions 1 and 2, both the sibling recurrence risk ratio and the sibling relative risk would be higher than they would be in the case where clustering was ignored (S. W. Guo and M. D. Wang, unpublished data).
Note that we have assumed no ascertainment bias in this paper. In practice, ascertainment bias can be common. For example, families with larger sibship are more likely to be ascertained than smaller ones, and families with at least one affected member are more likely to participate in genetic epidemiologic studies than families with none. In many cases, ascertainment biases are difficult to eliminate completely, even if the study is population-based. Therefore, it is a challenge to minimize the effect of ascertainment bias and to distinguish genuine effects of genetic or environmental factors from the effect of ascertainment bias. The greatest challenge, however, is the case in which there are many risk factors, each with a small effect on disease risk or weak familiality but interacting to contribute collectively to the familial aggregation of disease.
The sibling recurrence risk ratio, X s , has been used widely in human genetics, and it is often used as a measure of the effect of genetic factors underlying the disease of interest (6, 7) . It is perhaps somewhat surprising to some that the magnitude of X, s can be determined exclusively by environmental factors which aggregate familially.
Indeed, by their very definitions, both k s and £$, assuming that they can be estimated correctly, measure the degree of familial aggregation of disease. Neither of them tells us what causes the familiality of the disease or how. It is our intellectual construct that assumes the predicted pattern of X s , based on certain assumptions and models. Depending on our assumptions and theoretical models, we may arrive at conclusions quite differently regarding the cause of the disease familiality. In order to come to a trustworthy conclusion, however, it is important to make sure that the model is sufficiently realistic and that all of the underlying assumptions conform to reality as closely as possible. This, of course, is not all that easy in practice.
In view of the findings of this paper and other papers, several measures can be taken to minimize the effect of environmental similarity on familial aggregation of disease. First, care must be taken to adjust for ascertainment bias. In addition, data validation should be performed to see whether there exist misclassifications or overreporting among relatives of cases (5) . Second, in order to assess the environmental contribution to disease familiality, one must collect data on individual levels of risk exposures and estimate not only the strength of each individual risk factor but also the joint, interacting effect of two or more risk factors. Third, besides the does-response relationship between the extent of exposure and the strength of association between disease and risk factors, it is also necessary to measure correlation coefficients among relatives or familiality between all major risk factors. Moreover, crosscorrelation coefficients (i.e., the correlation coefficient between individual A's exposure to risk factor 1 and individual B's exposure to risk factor 2) should be measured. Fourth, when risk exposure is heterogeneous in the population, this should be taken into account accordingly. This is because failure to account for heterogeneity when it exists can lead to underestimation of familial aggregation of disease. Lastly, care should be exercised when risk factors are dichotomized, since dichotomization could underestimate familial aggregation of disease.
